Latest Revenue Guidance News

Chrysos Corporation reported robust FY25 results driven by record sample volumes and expanded global deployments of its PhotonAssay technology. The company reiterates strong FY26 guidance amid growing international partnerships.

Bubs Australia Limited reported a solid FY25 with $102.5 million revenue and outlined ambitious FY26 guidance targeting up to $125 million, driven by overseas markets and strategic investments.

EOS has bolstered its counter-drone arsenal by acquiring a UK-based interceptor business and securing a landmark €71.4 million export contract for its 100kW high energy laser system with The Netherlands.

The a2 Milk Company has raised its FY26 revenue guidance, citing stronger-than-expected performance in key product categories and favourable currency movements. The company anticipates solid earnings growth and robust cash flow conversion.

SKS Technologies has landed its largest data centre contract yet, a $130 million project in Melbourne, lifting its total work on hand to $304 million and prompting an upward revision of its FY26 revenue guidance.

Acusensus Limited has raised its FY26 revenue guidance to $83-$87 million, driven by significant new contracts in the US and New Zealand and expansions in Australia. This upgrade signals strong momentum in the company’s AI-powered road safety enforcement business.

Lycopodium Limited projects steady growth for FY26 with revenue guidance of $390-$410 million, underpinned by strong project momentum and the strategic SAXUM acquisition expanding its footprint in the Americas.

Life360 has reported a record-breaking third quarter in 2025, with significant growth in users, revenue, and profitability, while announcing a strategic acquisition to expand its advertising capabilities.

Etherstack plc reports a record-breaking FY25 with revenues up 62%, driven by major US and UK contracts, and projects continued strong growth into FY26 and beyond.

Monadelphous Group Limited has raised its revenue guidance for 2025, buoyed by strong contract awards and elevated activity across its engineering and construction divisions.

Etherstack’s subsidiary has landed a A$2.5 million contract with the Australian Defence, reinforcing its growing footprint in sovereign defence communications.

AVITA Medical reported a 13% drop in Q3 commercial revenue to $17.1 million but improved its net loss and secured CE Mark approval for RECELL GO in Europe, signaling strategic shifts ahead.